AOD-9604 in Shizhi — Fat Loss Peptide Research Guide
AOD-9604 research guide for Shizhi. HGH fragment studied for fat metabolism — covers mechanism, purity standards, COA verification, and how to source AOD-9604.
For anyone in Shizhi trying to locate AOD-9604, the first thing to know is that this compound moves through online research channels. This concentration of supply in online vendors is ultimately a quality advantage — top vendors compete on lab-verified purity in ways local stores never could. The key verification criteria for AOD-9604 are HPLC purity ≥98%, molecular identity verified through mass spectrometry, and a bacterial endotoxin panel — all documented in a lot-traced Certificate of Analysis. This guide gives Shizhi researchers the framework to assess vendor quality rigorously and source verified-quality AOD-9604 with confidence.
What Studies Say About AOD-9604
AOD-9604 belongs to the growth hormone secretagogue (GHS) class, compounds that stimulate pulsatile growth hormone release by acting on the ghrelin receptor (GHSR-1a) or growth hormone releasing hormone (GHRH) receptor. Ipamorelin, GHRP-2, GHRP-6, and Hexarelin all work primarily through GHSR-1a agonism, producing GH pulses with varying specificity profiles. CJC-1295 and Sermorelin work through the GHRH receptor, mimicking the natural hypothalamic signal for GH release. The downstream effect in both cases is increased pulsatile GH secretion and subsequent IGF-1 production in the liver. For researchers in Shizhi studying the GH-IGF-1 axis, this mechanistic clarity makes the GHS class a productive experimental tool.
How to Source AOD-9604 — Vendor Guide
Before assessing any particular supplier, build a clear picture of what a proper COA looks like — so you can tell whether a COA is complete and credible. A COA for AOD-9604 should include: HPLC purity percentage with the full chromatographic trace, mass spectrometry data verifying the correct molecular weight, endotoxin test results, and a residual solvent panel — all batch-matched. Community reputation in research forums is a valuable complement to COA verification — vendors with sustained positive community feedback have built their reputation on real product performance. Bacteriostatic water is the standard reconstitution medium for AOD-9604 — it contains 0.9% benzyl alcohol that prevents microbial contamination and extends reconstituted shelf life to 30 days refrigerated.
Order AOD-9604 — ships to Shizhi
COA-verified · International tracking · Research grade
All use of AOD-9604 in Shizhi or anywhere must be research use only — this compound is not approved for clinical human use, and all handling should comply with standard research safety practices. Lyophilised AOD-9604 should be frozen at −20°C as soon as it arrives; avoid repeatedly thawing and refreezing reconstituted peptide by preparing small aliquots before storage. The most significant preventable safety hazard in AOD-9604 research is endotoxin contamination from poor sourcing — a documented endotoxin result in your specific batch certificate is the specific protection against this risk. The research literature on AOD-9604 should be studied thoroughly before beginning any research — study approaches, dose levels, and measured endpoints vary significantly and conclusions do not uniformly extrapolate.
Frequently Asked Questions
How does AOD-9604 differ from growth hormone?
AOD-9604 contains only the fat-metabolism-relevant fragment of growth hormone (the C-terminal region) without the IGF-1-stimulating N-terminal domain. This means it targets fat cells' beta-adrenergic receptors for lipolytic effects without producing the anabolic IGF-1 signaling associated with full-length GH.
What is the clinical trial history of AOD-9604?
AOD-9604 has undergone multiple Phase II clinical trials for obesity treatment by Metabolic Pharmaceuticals in Australia. The trials showed safety and tolerability but mixed efficacy results for weight loss. It holds GRAS (Generally Recognized As Safe) status from the FDA for food use, which is unusual for research peptides.
What is AOD-9604?
AOD-9604 is a synthetic peptide analogue of the C-terminal fragment of human growth hormone (amino acids 177-191), with an additional tyrosine residue at the N-terminus. It has been studied for fat metabolism effects, specifically lipolysis stimulation and lipogenesis inhibition, without the IGF-1-stimulating effects of full-length GH. It has undergone clinical trials for obesity treatment.
